Cerus Corporation
CERS
#7903
Rank
A$0.56 B
Marketcap
A$2.79
Share price
-2.63%
Change (1 day)
19.38%
Change (1 year)

Earnings for Cerus Corporation (CERS)

Earnings in 2026 (TTM): -A$0.36 Million

According to Cerus Corporation's latest financial reports the company's current earnings are A$0.22 Billion. In 2025 the company made an earning of -A$10.49 Million, an increase over its 2024 earnings that were of -A$17.95 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cerus Corporation from 1997 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$0.36 Million-96.65%
2025 -A$10.49 Million-41.58%
2024 -A$17.95 Million-58.95%
2023 -A$43.72 Million-20.74%
2022 -A$55.16 Million-25.7%
2021 -A$74.24 Million-11.99%
2020 -A$84.35 Million-14%
2019 -A$98.08 Million21.73%
2018 -A$80.57 Million-0.65%
2017 -A$81.1 Million-10.96%
2016 -A$91.09 Million4.24%
2015 -A$87.38 Million50.99%
2014 -A$57.87 Million-10.08%
2013 -A$64.36 Million184.13%
2012 -A$22.66 Million-7.91%
2011 -A$24.6 Million
2009 -A$34.74 Million-24.69%
2008 -A$46.13 Million-25.2%
2007 -A$61.67 Million330.54%
2006 -A$14.33 Million1.49%
2005 -A$14.12 Million-61.02%
2004 -A$36.21 Million
2002 -A$89.56 Million10.02%
2001 -A$81.4 Million34.25%
2000 -A$60.64 Million61.02%
1999 -A$37.66 Million-18.81%
1998 -A$46.39 Million93.08%
1997 -A$24.03 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Boston Scientific
BSX
A$5.33 B-1,497,557.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Utah Medical Products
UTMD
A$19.46 M-5,558.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Haemonetics
HAE
A$0.26 B-75,078.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-A$24.96 Million 6,900.00%๐Ÿ‡บ๐Ÿ‡ธ USA